Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

scPharmaceuticals, Inc. (SCPH) had Revenue of $16.04M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$16.04M
Net Income	$-18.02M
Cost of Goods Sold	$5.01M
Gross Profit	$11.03M
Operating Expenses	$30.34M
Operating Income	$-14.29M
Non-Operating Income/Expense	$-3.73M
Pre-Tax Income	$-18.02M
Normalized Pre-Tax Income	$-18.02M
Income after Taxes	$-18.02M
Income from Continuous Operations	$-18.02M
Consolidated Net Income/Loss	$-18.02M
Normalized Income after Taxes	$-18.02M
EBIT	$-14.29M
EBITDA	$-14.23M
Weighted-Average Shares Outstanding (Basic)	53.72M
Weighted-Average Shares Outstanding (Diluted)	53.72M
Earnings per Share (EPS) (Basic)	$-0.34
Earnings per Share (EPS) (Diluted)	$-0.34
Balance Sheet Financials
Current Assets	$78.73M
Property, Plant, and Equipment	$0.05M
Long-Term Assets	$1.53M
Total Assets	$80.25M
Current Liabilities	$20.43M
Long-Term Debt	$51.20M
Long-Term Liabilities	$81.14M
Total Liabilities	$101.57M
Common Equity	$-21.32M
Tangible Shareholders Equity	$-21.32M
Shareholders Equity	$-21.32M
Common Shares Outstanding	53.29M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-33.25M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$-1.60M
Beginning Cash	$75.66M
End Cash	$40.81M
Increase/Decrease in Cash	$-34.85M
Stock-Based Compensation	$2.81M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.85
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.71
Debt to Equity Ratio	-2.40
Gross Margin	68.76%
Operating Margin	-89.11%
EBIT Margin	-89.11%
EBITDA Margin	--
Pre-Tax Profit Margin	-112.36%
Profit Margin	-112.36%
Free Cash Flow	$-33.25M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.20
Inventory Turnover	0.34
Receiveable Turnover	0.83
Days Sales in Receivables	108.90
Return on Equity	84.56%
Return on Tangible Equity	84.56%
Return on Assets	-22.46%
Return on Investments	-60.31%
Book Value Per Share	$-0.40
Free Cash Flow per Share	$-0.62
Operating Cash Flow per Share	$-0.62

Data from Zacks Investment Research, Inc.